Visceral Fat Is an Independent Predictor of All‐cause Mortality in Men
By J. Kuk, P. Katzmarzyk, M. Nichaman, T. Church, S. Blair, R. Ross. Obesity, 2006
667 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/2e2de3e49a6dc28e56fe11ef71f3d23e57c5ffdc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Epidemiology
In Physiology
- B. Saltin
- B. K. Pedersen
- J. Despres
- André Tchernof
- M. Ibrahim
- M. Blüher
- M. C. Severinsen
- P. Trayhurn
Citations in the corpus
- Pathophysiology of human visceral obesity: an update. (2013, background): “(278) examined 291 men (97 decedents and 194 controls) from the preventive medicine clinic in Dallas, Texas to establish whether abdominal fat was independently linked to mortality.”
- Waist‐to‐height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta‐analysis (2012, neutral): “These invariably relate to the high metabolic and inflammatory activity of the visceral fat depots within the abdominal cavity (55) in comparison to subcutaneous depots in other parts of the body such as the gluteo-femoral region (56).”
- Subcutaneous and visceral adipose tissue: structural and functional differences (2010, background): “Visceral fat is a strong, independent predictor of all-cause mortality in men (68).”
- Insulin-sensitive obesity. (2010, background): “These depot-specific differences may contribute to the independent curvilinear association between visceral adiposity and mortality (25).”
- Age-related changes in total and regional fat distribution. (2009, neutral): “…known to be strongly associated with several deleterious health outcomes such as dyslipidemia (Tiikkainen et al., 2002; Nguyen-Duy et al., 2003; Lemieux, 2004), insulin resistance (Lewis et al., 2002; Tiikkainen et al., 2002) and even mortality (Kuk et al., 2006), as discussed later in the review.”
- Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases (2015, background): “…et al., 2003; Janiszewski et al., 2008), lower glucose tolerance (Janssen et al., 2002), insulin resistance (Ross et al., 2002), systemic inflammation (Forouhi et al., 2001), hypertension (Hayashi et al., 2004), type 2 diabetes (Boyko et al., 2000), and allcause mortality (Kuk et al., 2006).”
- Visceral fat: A key mediator of steatohepatitis in metabolic liver disease (2008, neutral): “Steatosis 12 (32%) Steatohepatitis 26 (68%) Age (years) 51 (12) Male gender 22 (58%) BMI (kg/m2) 30 (4) Overweight 17 (45%) Obese 16 (42%) Metabolic syndrome criteria* met Waist 26 (68%) Blood pressure 16 (42%) Triglycerides 25 (66%) HDL 12 (32%) Glucose 18 (47%) Three or more 20 (53%) Diabetic 9 (2”